Share this post on:

Product Name :
Clarithromycin/Clofazimine/Rifabutin

Search keywords :
Clofazimine

drugId :
null

Target Vo:
50S ribosomal subunit

Target Vo Short Name :
50S ribosomal subunit

Moa_Name:
DNA inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Centre For Digestive Diseases

Active Company_Name :
Redhill Biopharma Ltd

Active Indication_Name:
Lung Diseases

In Active Indication_Name:
Multiple Sclerosis, Relapsing-Remitting

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Farletuzumab ecteribulin Antibody-Drug Conjugates (ADCs)
LAMP1 Rabbit mAb supplier
nNOS Antibody: nNOS Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 161 kDa, targeting to nNOS. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related